Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-044549
Filing Date
2007-03-01
Accepted
2007-03-01 17:18:35
Documents
12
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1427708
2 AMENDED BYLAWS OF THE REGISTRANT dex32.htm EX-3.2 87129
3 RETENTION AGREEMENT BETWEEN REGISTRANT AND THOMAS H. SILBERG dex1024.htm EX-10.24 48834
4 RETENTION AGREEMENT BETWEEN REGISTRANT AND FRANK HARMON dex1025.htm EX-10.25 48734
5 CODE OF BUSINESS CONDUCT dex141.htm EX-14.1 101520
6 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 8701
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2664
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - SECTION 302 dex311.htm EX-31.1 9241
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER - SECTION 302 dex312.htm EX-31.2 9216
10 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - SECTION 906 dex321.htm EX-32.1 4007
11 CERTIFICATION OF CHIEF FINANCIAL OFFICER - SECTION 906 dex322.htm EX-32.2 4220
12 GRAPHIC g12868imag001.jpg GRAPHIC 20380
  Complete submission text file 0001193125-07-044549.txt   1781998
Mailing Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837
Business Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837 847-969-2700
Abraxis BioScience, Inc. (Filer) CIK: 0001141399 (see all company filings)

EIN.: 680389419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-33407 | Film No.: 07664644
SIC: 2834 Pharmaceutical Preparations